These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 18562425)

  • 1. Modafinil treatment of amphetamine abuse in adult ADHD.
    Mann N; Bitsios P
    J Psychopharmacol; 2009 Jun; 23(4):468-71. PubMed ID: 18562425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of the use of modafinil for attention-deficit hyperactivity disorder.
    Turner D
    Expert Rev Neurother; 2006 Apr; 6(4):455-68. PubMed ID: 16623645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dual diagnosis of attention-deficit/hyperactivity disorder and substance abuse: case reports and literature review.
    Schubiner H; Tzelepis A; Isaacson JH; Warbasse LH; Zacharek M; Musial J
    J Clin Psychiatry; 1995 Apr; 56(4):146-50. PubMed ID: 7713853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of modafinil for the treatment of attention deficit/hyperactivity disorder.
    Lindsay SE; Gudelsky GA; Heaton PC
    Ann Pharmacother; 2006 Oct; 40(10):1829-33. PubMed ID: 16954326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind and placebo-controlled trial of modafinil in children and adolescents with attention deficit and hyperactivity disorder.
    Kahbazi M; Ghoreishi A; Rahiminejad F; Mohammadi MR; Kamalipour A; Akhondzadeh S
    Psychiatry Res; 2009 Aug; 168(3):234-7. PubMed ID: 19439364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of hyperactivity and attention deficit with amphetamine. Experience with five adult prisoners].
    Stovner AM; Wyller TB; Skulberg A; Os L; Korsmo G
    Tidsskr Nor Laegeforen; 1996 Jun; 116(17):2002-5. PubMed ID: 8766640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological treatment of amphetamine dependence still on unsafe basis].
    Franck J
    Lakartidningen; 2011 Oct 9-15; 108(45):2304-7. PubMed ID: 22242247
    [No Abstract]   [Full Text] [Related]  

  • 8. Attention-deficit-hyperactivity disorder: an update.
    Dopheide JA; Pliszka SR
    Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Collicular dysfunction in attention deficit hyperactivity disorder.
    Overton PG
    Med Hypotheses; 2008; 70(6):1121-7. PubMed ID: 18215471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treating adult attention deficit hyperactivity disorder in hospitalized psychiatric patients.
    Castaneda R; Levy R; Hazzi C; Ross S; Roman W; Hamid H
    Gen Hosp Psychiatry; 2008; 30(6):572-7. PubMed ID: 19061685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modafinil for bipolar depression with comorbid methamphetamine abuse.
    Camacho A; Ng B; Frye MA
    Am J Addict; 2010; 19(2):190-1. PubMed ID: 20163392
    [No Abstract]   [Full Text] [Related]  

  • 12. Amphetamine treatment similar to that used in the treatment of adult attention-deficit/hyperactivity disorder damages dopaminergic nerve endings in the striatum of adult nonhuman primates.
    Ricaurte GA; Mechan AO; Yuan J; Hatzidimitriou G; Xie T; Mayne AH; McCann UD
    J Pharmacol Exp Ther; 2005 Oct; 315(1):91-8. PubMed ID: 16014752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attention deficit hyperactivity disorder (ADHD)--life insurance implications.
    Cotlar MJ
    J Insur Med; 2003; 35(1):51-6. PubMed ID: 14694825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rare case of dependence on pemoline.
    Bonnet U; Davids E
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep; 30(7):1340-1. PubMed ID: 16600453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Amphetamine misuse in suspected adult ADHS syndrome].
    Soyka M; Sievers E; Fischer-Erlewein E
    Gesundheitswesen; 2009 Apr; 71(4):207-9. PubMed ID: 19259920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Attention deficit hyperactivity disorder in adults].
    Roizblatt A; Bustamante F; Bacigalupo F
    Rev Med Chil; 2003 Oct; 131(10):1195-201. PubMed ID: 14692312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bipolar disorders and quality of life: the impact of attention deficit/hyperactivity disorder and substance abuse in euthymic patients.
    Sentissi O; Navarro JC; De Oliveira H; Gourion D; Bourdel MC; Baylé FJ; Olié JP; Poirier MF
    Psychiatry Res; 2008 Oct; 161(1):36-42. PubMed ID: 18786727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is adult attention deficit hyperactivity disorder a valid diagnosis in the presence of high IQ?
    Antshel KM; Faraone SV; Maglione K; Doyle A; Fried R; Seidman L; Biederman J
    Psychol Med; 2009 Aug; 39(8):1325-35. PubMed ID: 19105857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attention-deficit/hyperactivity disorder in adults: evidence-based recommendations for management.
    Rostain AL
    Postgrad Med; 2008 Sep; 120(3):27-38. PubMed ID: 18824823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symptoms and sleep patterns during inpatient treatment of methamphetamine withdrawal: a comparison of mirtazapine and modafinil with treatment as usual.
    McGregor C; Srisurapanont M; Mitchell A; Wickes W; White JM
    J Subst Abuse Treat; 2008 Oct; 35(3):334-42. PubMed ID: 18329221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.